- Home
- NMRA vs PDLB Comparison
NMRA vs PDLB Comparison
Compare NMRA & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- PDLB
- Stock Information
- Founded
- NMRA 2019
- PDLB 1960
- Country
- NMRA United States
- PDLB United States
- Employees
- NMRA N/A
- PDLB N/A
- Industry
- NMRA
- PDLB
- Sector
- NMRA
- PDLB
- Exchange
- NMRA Nasdaq
- PDLB Nasdaq
- Market Cap
- NMRA 121.0M
- PDLB 316.6M
- IPO Year
- NMRA 2023
- PDLB 2017
- Fundamental
- Price
- NMRA $0.90
- PDLB $14.16
- Analyst Decision
- NMRA Buy
- PDLB
- Analyst Count
- NMRA 8
- PDLB 0
- Target Price
- NMRA $9.29
- PDLB N/A
- AVG Volume (30 Days)
- NMRA 1.4M
- PDLB 40.6K
- Earning Date
- NMRA 08-05-2025
- PDLB 07-29-2025
- Dividend Yield
- NMRA N/A
- PDLB N/A
- EPS Growth
- NMRA N/A
- PDLB 148.96
- EPS
- NMRA N/A
- PDLB 0.60
- Revenue
- NMRA N/A
- PDLB $86,682,000.00
- Revenue This Year
- NMRA N/A
- PDLB $10.97
- Revenue Next Year
- NMRA N/A
- PDLB $8.59
- P/E Ratio
- NMRA N/A
- PDLB $23.84
- Revenue Growth
- NMRA N/A
- PDLB 18.40
- 52 Week Low
- NMRA $0.61
- PDLB $9.02
- 52 Week High
- NMRA $17.19
- PDLB $14.46
- Technical
- Relative Strength Index (RSI)
- NMRA 58.51
- PDLB 63.17
- Support Level
- NMRA $0.72
- PDLB $13.76
- Resistance Level
- NMRA $0.85
- PDLB $14.32
- Average True Range (ATR)
- NMRA 0.07
- PDLB 0.28
- MACD
- NMRA 0.00
- PDLB 0.09
- Stochastic Oscillator
- NMRA 82.55
- PDLB 81.82
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.